📰 Michael Karin News
Page 2 - Michael Karin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Karin. Real-time updates on events, politics, business and more.
April 13, 2023
Liver cancer is the third leading cause of cancer death and the sixth most common cancer type worldwide.
April 13, 2023
UC San Diego scientists find a protein associated with liver cancer may actually be the key to protecting against it. By blocking ferroptosis, a form of liver cell death, the protein prevents liver damage and its progression to cancer.
March 3, 2023
PALO ALTO, Calif.--(BUSINESS WIRE)--#AML--Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a private, clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting myeloid checkpoints, announced today its plans to present on the company’s myeloid biology research and clinical stage programs at...
October 6, 2022
The most prevalent and fatal kind of pancreatic cancer is pancreatic ductal adenocarcinoma (PDAC). PDAC patients have a 5-year survival rate of only 7.1 per cen
July 14, 2022
Researchers describe the biochemical pathway that leads to inflammation characteristic of autoimmune diseases, which could lead to anti-inflammatory therapies
July 13, 2022
Mitochondria are self-contained organelles (they possess their own mini-chromosome and DNA) residing within cells and are charged with the job of generating the chemical energy needed to fuel functions essential to life and well-being.
November 22, 2021
Fifty-one faculty members and researchers at the University of California San Diego have been cited as among the world’s most influential in their fields, according to the 2021 Clarivate listing of Most Highly Cited Researchers in the World.Clarivate
June 11, 2021
Metformin is a widely prescribed blood sugar-lowering drug. It is often used as an early therapy (in combination with diet and lifestyle changes) for type 2 diabetes, which afflicts more than 34 million Americans.
June 10, 2021
Researchers identify molecular mechanism for the anti-inflammatory activity of diabetes drug metformin and, in mouse studies, say it prevents lung inflammation in animals infected with SARS-CoV-2, the virus that causes COVID-19.